Sponsor Pipeline

Spruce Biosciences Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07733856 Early Access Treatment With Tralesinidase Alfa in Mucopolysaccharidosis Type IIIB… Available
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07579910 Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo… MPS IIIB Not Yet Recruiting
Get alerts when Spruce Biosciences's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free